MAPT and tauopathy: However, HDAC6 KD in tauopathy mice did not lower tau pathology (Valencia et al., 2021), and HDAC6 knock-out resulted in increased tau pathology and shortened lifespan in tau transgenic mice (Trzeciakiewicz et al., 2020).